Home/Filings/4/0000927066-24-000037
4//SEC Filing

STAFFIERI MICHAEL DAVID 4

Accession 0000927066-24-000037

CIK 0000927066other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 6:13 PM ET

Size

10.9 KB

Accession

0000927066-24-000037

Insider Transaction Report

Form 4
Period: 2024-03-13
STAFFIERI MICHAEL DAVID
COO, Kidney Care
Transactions
  • Disposition to Issuer

    Common Stock

    2024-03-13$139.21/sh18,825$2,620,62883,923 total
  • Tax Payment

    Common Stock

    2024-03-13$139.21/sh15,800$2,199,51868,123 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-03-1350,0000 total
    Exercise: $52.41From: 2022-06-20Exp: 2024-06-20Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-13$52.41/sh+50,000$2,620,500102,748 total
Holdings
  • Common Stock

    (indirect: By Trust)
    158,506
Footnotes (3)
  • [F1]Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
  • [F2]Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
  • [F3]The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023.

Issuer

DAVITA INC.

CIK 0000927066

Entity typeother

Related Parties

1
  • filerCIK 0001604063

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 6:13 PM ET
Size
10.9 KB